Cargando…
A statistical perspective on baseline adjustment in pharmacogenomic genome-wide association studies of quantitative change
In pharmacogenetic (PGx) studies, drug response phenotypes are often measured in the form of change in a quantitative trait before and after treatment. There is some debate in recent literature regarding baseline adjustment, or inclusion of pre-treatment or baseline value as a covariate, in PGx geno...
Autores principales: | Zhang, Hong, Chhibber, Aparna, Shaw, Peter M., Mehrotra, Devan V., Shen, Judong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184591/ https://www.ncbi.nlm.nih.gov/pubmed/35680959 http://dx.doi.org/10.1038/s41525-022-00303-2 |
Ejemplares similares
-
The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change
por: Oni-Orisan, Akinyemi, et al.
Publicado: (2020) -
Multi-trait analysis of rare-variant association summary statistics using MTAR
por: Luo, Lan, et al.
Publicado: (2020) -
Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
por: Zhai, Song, et al.
Publicado: (2022) -
Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
por: Bienfait, Karina, et al.
Publicado: (2021) -
Genome Wide Analysis Reveals Host Genetic Variants that Associate with Reduction in Clostridium difficile Infection Recurrence (rCDI) in Patients Treated with Bezlotoxumab
por: Shaw, Peter, et al.
Publicado: (2017)